QL1706
Showing 1 - 16 of 16
Colorectal Carcinoma Trial in Shanghai (QL1706, Bevacizumab, Oxaliplatin injection)
Recruiting
- Colorectal Carcinoma
- QL1706
- +3 more
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Mar 23, 2023
Hepatocellular Carcinoma Trial in Nanjing, Shanghai (QL1706, Bevacizumab, Oxaliplatin injection)
Not yet recruiting
- Hepatocellular Carcinoma
- QL1706
- +4 more
-
Nanjing, Jiangsu, China
- +1 more
Jul 28, 2023
Advanced Liver Cancer Trial in Chengdu (QL1706, QL1604, Bevacizumab)
Recruiting
- Advanced Liver Cancer
- QL1706
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Nov 1, 2022
Cervical Cancer Trial in Guangzhou (QL1706)
Recruiting
- Cervical Cancer
- QL1706
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Sep 23, 2022
Nasopharyngeal Carcinoma Trial in Guangzhou (QL1706, Carrelizumab, Gemcitabine)
Recruiting
- Nasopharyngeal Carcinoma
- QL1706
- +3 more
-
Guangzhou, Guangzhou, ChinaSun Yat-sen University Cancer Center
Oct 21, 2022
METASTATIC CERVICAL CANCER Trial (QL1706, Placebo)
Recruiting
- METASTATIC CERVICAL CANCER
- QL1706
- +3 more
-
Chongqing, Chongqing, China
- +2 more
Nov 24, 2022
Esophageal Squamous Cell Carcinoma Trial (QL1706)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
- QL1706
- (no location specified)
Aug 4, 2022
Extensive-stage Small-cell Lung Cancer Trial in Hangzhou (QL1706, Carboplatin, Etoposide)
Recruiting
- Extensive-stage Small-cell Lung Cancer
- QL1706
- +2 more
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Jul 13, 2022
NSCLC Trial (QL1706 injection, Vinorelbine Tartrate, Paclitaxel)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- QL1706 injection
- +6 more
- (no location specified)
Aug 3, 2022
Advanced Renal Cell Carcinoma Trial (QL1706 Plus Lenvatinib)
Not yet recruiting
- Advanced Renal Cell Carcinoma
- QL1706 Plus Lenvatinib
- (no location specified)
Feb 21, 2022
Non-small-cell Lung Cancer Trial (QL1706)
Not yet recruiting
- Non-small-cell Lung Cancer
- QL1706
- (no location specified)
Apr 7, 2022
Advanced Solid Tumors Trial in Guangzhou (QL1706 injection)
Active, not recruiting
- Advanced Solid Tumors
- QL1706 injection
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Dec 27, 2021
Advanced Malignant Tumor Trial in Guangzhou (QL1706)
Unknown status
- Advanced Malignant Tumor
- QL1706
-
Guangzhou, Guangdong, ChinaSun Yat-sen Univeisity Cancer Center
Mar 3, 2020
Breast Cancer Trial in Worldwide (Abemaciclib, Standard Adjuvant Endocrine Therapy)
Active, not recruiting
- Breast Cancer
- Abemaciclib
- Standard Adjuvant Endocrine Therapy
-
Birmingham, Alabama
- +611 more
Jan 21, 2022